Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging

Hepatic steatosis is frequently observed in obese and aged individuals. Because hepatic steatosis is closely associated with metabolic syndromes, including insulin resistance, dyslipidemia, and inflammation, numerous efforts have been made to develop compounds that ameliorate it. Here, a novel perox...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncotarget
المؤلفون الرئيسيون: Kim, Seong Min, Lee, Bonggi, An, Hye Jin, Kim, Dae Hyun, Park, Kyung Chul, Noh, Sang-Gyun, Chung, Ki Wung, Lee, Eun Kyeong, Kim, Kyung Mok, Kim, Do Hyun, Kim, Su Jeong, Chun, Pusoon, Lee, Ho Jeong, Moon, Hyung Ryong, Chung, Hae Young
التنسيق: Artigo
اللغة:Inglês
منشور في: Impact Journals LLC 2017
الموضوعات:
Research Paper
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542266/
https://ncbi.nlm.nih.gov/pubmed/28545035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17695
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة